Fiera Capital Corp Acquires Shares of 260,000 ASP Isotopes Inc. (NASDAQ:ASPI)

Fiera Capital Corp bought a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 260,000 shares of the company’s stock, valued at approximately $723,000. Fiera Capital Corp owned 0.38% of ASP Isotopes at the end of the most recent quarter.

A number of other large investors have also modified their holdings of ASPI. Vanguard Group Inc. grew its holdings in ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after acquiring an additional 844,705 shares during the period. Marshall Wace LLP grew its stake in shares of ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after purchasing an additional 433,734 shares during the period. Rathbones Group PLC increased its holdings in shares of ASP Isotopes by 27.5% in the 2nd quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock valued at $600,000 after purchasing an additional 42,243 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of ASP Isotopes by 5.7% in the second quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock valued at $526,000 after purchasing an additional 9,200 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in ASP Isotopes during the second quarter worth about $381,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Canaccord Genuity Group assumed coverage on shares of ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 target price for the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price objective on shares of ASP Isotopes in a research note on Friday, October 18th. Finally, HC Wainwright lowered their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a report on Wednesday, August 7th.

ASP Isotopes Price Performance

Shares of NASDAQ:ASPI opened at $8.77 on Monday. The company has a debt-to-equity ratio of 2.06, a quick ratio of 4.00 and a current ratio of 4.00. The business’s fifty day moving average price is $3.89 and its two-hundred day moving average price is $3.55. The stock has a market cap of $624.07 million, a PE ratio of -13.92 and a beta of 3.88. ASP Isotopes Inc. has a one year low of $1.09 and a one year high of $9.23.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The company had revenue of $1.02 million during the quarter. On average, analysts forecast that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.